Veterinary Medicine Market to Reach USD 91.42 Billion by 2031 as Pet Humanization and Telemedicine Accelerate Growth

As pets increasingly occupy the role of family members rather than mere companions, spending on their healthcare is climbing sharply, and global livestock health needs are compounding that growth. According to new research on the Veterinary Medicine Market, global revenue is projected to grow from USD 51.80 billion in 2024 to USD 91.42 billion by 2031, reflecting a compound annual growth rate of 8.45%. The market, valued at USD 48.25 billion in 2023, is being driven by rising pet ownership, growing prevalence of animal disease, and continuous advancement in veterinary medicine and technology.

A Market Spanning Companion Animals and Livestock

Veterinary medicine encompasses the prevention, diagnosis, and treatment of disorders, diseases, and injuries in both companion animals and livestock. The market includes pharmaceutical and biologics companies producing antibiotics, antiparasitics, vaccines, and gene therapies, distributed through veterinary clinics and hospitals, pharmacies, online retailers, and pet stores. Major players in this space include Zoetis, Merck & Co., Boehringer Ingelheim, Elanco, IDEXX, Proclinica, Dechra Pharmaceuticals, Vetoquinol, Virbac, and Hester Biosciences.

Growth in this market is being reinforced by a broader global trend: the world's expanding population is driving increased demand for animal-derived protein sources, placing greater emphasis on livestock health and veterinary care as a critical link in the global food supply chain.

The Humanization of Pets Reshapes Spending Patterns

One of the most powerful forces reshaping this market is the ongoing "humanization" of pets — a cultural shift in which companion animals are increasingly regarded as full-fledged family members. This shift is translating directly into greater discretionary spending on pet care, including routine check-ups, vaccinations, and dental treatment, and is fueling growth in the number of veterinary clinics and hospitals along with increased investment in infrastructure, equipment, and personnel.

Investor interest in this trend is substantial. One urgent veterinary care provider recently raised USD 36 million in a Series C funding round, with plans to expand to forty clinics across ten major markets in order to provide more accessible, high-quality veterinary care — a clear signal of the capital flowing into the sector as consumer demand for premium pet healthcare continues to build.

Preventive Care and Wellness Programs Gain Priority

Rising incomes and growing pet populations are together fueling greater emphasis on preventive healthcare and overall animal wellness. Pet owners are increasingly prioritizing services such as parasite control, nutritional management, and early disease detection, recognizing the long-term value of preventive care in maintaining animal health while reducing future treatment costs. This shift is prompting veterinary clinics to expand comprehensive wellness programs and lifestyle management services, strengthening their value proposition to increasingly health-conscious pet owners.

Zoonotic Disease Concerns Drive Preventive Medicine

Beyond companion animal trends, the global rise in animal disease — including infections, chronic conditions, and inflammatory disorders — is fueling substantial demand for veterinary medicine. Animals, like humans, are increasingly affected by chronic diseases such as diabetes mellitus, cancer, and kidney disease, driving demand for long-term treatment and medication regimens.

Compounding this trend is a growing awareness of zoonotic disease risk. Global animal health authorities report that zoonotic diseases — those transmitted between animals and humans — cause an estimated 2.5 billion cases of illness and 2.7 million human deaths annually. This sobering statistic underscores why vaccination and preventive care for animals carrying diseases like rabies, leptospirosis, and Lyme disease has become an increasingly urgent public health priority, not merely an animal welfare concern.

Veterinary Telemedicine Expands Access

Digital health platforms are transforming how pet owners, particularly those in remote areas, access veterinary care. The growing demand for telemedicine and virtual veterinary consultation is prompting rapid development of digital health platforms and mobile apps that help owners manage their animals' health, track medications, and access veterinary guidance remotely. One notable partnership brought together a pet care startup and a leading veterinary telemedicine platform to expand access to 24/7 virtual consultations and streamlined appointment scheduling — illustrating how digital-first care models are becoming mainstream even in a traditionally in-person field.

Segmentation: Pharmaceuticals and Companion Animals Lead

By product type, the market is divided into pharmaceuticals and biologics, with pharmaceuticals leading in 2023 at roughly USD 25.93 billion in revenue. This segment spans antibiotics, antivirals, anti-inflammatory drugs, and cardiovascular medications, playing a crucial role in developing innovative therapies for infections, pain management, and chronic disease treatment in animals. Substantial R&D investment continues to focus on developing treatments with minimized side effects for prevalent chronic conditions such as cancer, diabetes, and arthritis.

By animal type, companion animals represent the fastest-growing segment, projected to generate roughly USD 30.09 billion in revenue in 2024. Rising ownership of dogs, cats, horses, reptiles, and birds has driven increased veterinary spending, as owners become more aware of the benefits of preventive care — boosting demand for vaccinations, parasite control, dental care, and routine check-ups.

By distribution channel, veterinary clinics and hospitals represent the fastest-growing category, projected to generate roughly USD 37.91 billion in revenue by 2031, driven by rising demand for advanced diagnostics and specialized treatment. Many clinics now offer sophisticated diagnostic procedures including MRI, CT scans, and ultrasound for animals, while consumer demand for comprehensive, one-stop veterinary care is fueling growth in multi-service veterinary hospitals.

By route of administration, oral medications are expected to see particularly strong growth, expanding at a CAGR of roughly 8.97%. Oral formulations — including tablets, capsules, pastes, and gels — offer significant advantages in terms of animal comfort and ease of administration compared to injectables, making them especially well-suited to long-term treatment protocols that pet owners can manage at home. One recent regulatory approval covers an oral parasiticide offering protection against six different parasites, including fleas, ticks, heartworm, roundworms, tapeworms, and hookworms.

Regulatory Complexity Remains a Key Challenge

Despite strong growth fundamentals, the veterinary medicine industry faces meaningful challenges related to market access and regulatory compliance. Varying regulatory requirements across different countries governing the development, manufacturing, and marketing of veterinary medicines create significant complexity, adding to both the time and expense companies face when bringing new products to market. In response, industry participants are forming associations to engage proactively with regulatory agencies, aiming to streamline compliance processes across jurisdictions.

Regional Analysis: North America Leads, Asia-Pacific Accelerates

North America accounted for roughly 36.73% of the global veterinary medicine market in 2023, valued at approximately USD 17.72 billion. Growth in the region is closely tied to the expanding companion animal population and the increasing availability of pet insurance, which has significantly boosted utilization of veterinary care by easing the financial burden on pet owners. Recent data shows the North American pet insurance market generated USD 4.27 billion in premiums, representing a substantial 21% increase over the prior year — a clear indicator of accelerating adoption among households seeking to manage unexpected veterinary costs.

Asia-Pacific has emerged as the fastest-growing region, projected to expand at a CAGR of roughly 9.65% through 2031. Rising disposable income and growing demand for animal protein are key growth drivers, as increasingly intensive livestock production to meet demand for meat, milk, and eggs raises the need for veterinary services to prevent and control disease in animal populations, while growing awareness of zoonotic disease risk is further fueling demand for preventive veterinary medicine.

Recent Industry Developments

Consolidation continues to shape the competitive landscape. One market leader acquired a protein-based animal health therapeutics company to expand its portfolio in monoclonal antibody therapeutics for chronic diseases in cats and dogs. Separately, a major biopharmaceutical company acquired an animal health firm focused on novel therapeutic medicines, aiming to strengthen its research and development capabilities in the pet therapeutics segment. Strategic partnerships are also expanding client access to comprehensive animal health support, including disease and pain management services delivered through collaborative veterinary networks.

Outlook

With a projected CAGR of 8.45% through 2031, the veterinary medicine market is positioned for sustained, multi-faceted growth. As pet humanization continues to reshape consumer spending, zoonotic disease awareness drives preventive care investment, and telemedicine expands access to veterinary services, the industry appears well positioned to remain one of the more resilient and dynamic segments of the broader global healthcare economy.